middle.news
How Island Pharmaceuticals’ FDA Feedback Sparks $9m Capital Boost
11:02am on Tuesday 10th of February, 2026 AEDT
•
Healthcare
Read Story
How Island Pharmaceuticals’ FDA Feedback Sparks $9m Capital Boost
11:02am on Tuesday 10th of February, 2026 AEDT
Key Points
FDA feedback deemed material to share price and regulatory progress
Trading halt requested to manage disclosure and market orderliness
Unintentional breach of ASX Listing Rule 15.7 during capital raising
$9 million placement secured to fund Galidesivir development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ILA
OPEN ARTICLE